Given that sPLA2-IIF is expressed in the epidermis rather specifically and that Pla2g2f−/− mice display more profound skin phenotypes in diseases than in homeostasis, inhibition of this particular sPLA2 may be useful for treatment of psoriasis, skin cancer, or other conditions involving epidermal hyperplasia. This evidence concerns the gene PLA2G2F and skin neoplasm.